MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses
Main Authors: | Hessel, Annett, Savidis-Dacho, Helga, Coulibaly, Sogue, Portsmouth, Daniel, Kreil, Thomas R., Crowe, Brian A., Schwendinger, Michael G., Pilz, Andreas, Barrett, P. Noel, Falkner, Falko G., Schäfer, Birgit |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921149/ |
Similar Items
-
H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
by: Howard, M. Keith, et al.
Published: (2011) -
Immunogenicity and Protective Efficacy of a Vero Cell Culture-Derived Whole-Virus H7N9 Vaccine in Mice and Guinea Pigs
by: Wodal, Walter, et al.
Published: (2015) -
Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever
by: Schäfer, Birgit, et al.
Published: (2011) -
Selection of recombinant MVA by rescue of the essential D4R gene
by: Ricci, Patricia S, et al.
Published: (2011) -
Evaluation of OspA Vaccination-Induced Serological Correlates of Protection against Lyme Borreliosis in a Mouse Model
by: Schwendinger, Michael G., et al.
Published: (2013)